Alexander Staab

Biberach An Der Riss, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025.

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025.

Journal: CPT: pharmacometrics & systems pharmacology

Published: December 07, 2025

Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.

Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.

Journal: CPT: pharmacometrics & systems pharmacology

Published: December 19, 2024

Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences.

Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences.

Journal: CPT: pharmacometrics & systems pharmacology

Published: June 20, 2019

Modeling Exposure-Driven Adverse Event Time Courses in Oncology Exemplified by Afatinib.

Modeling Exposure-Driven Adverse Event Time Courses in Oncology Exemplified by Afatinib.

Journal: CPT: pharmacometrics & systems pharmacology

Published: August 27, 2018

Model-Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future Perspectives.

Model-Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future Perspectives.

Journal: CPT: pharmacometrics & systems pharmacology

Published: August 13, 2018

Model-based evaluation of pulmonary pharmacokinetics in asthmatic and COPD patients after oral olodaterol inhalation.

Model-based evaluation of pulmonary pharmacokinetics in asthmatic and COPD patients after oral olodaterol inhalation.

Journal: British journal of clinical pharmacology

Published: December 16, 2015

Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation.

Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation.

Journal: CPT: pharmacometrics & systems pharmacology

Published: July 30, 2015

Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach.

Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach.

Journal: British journal of clinical pharmacology

Published: May 28, 2015

Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus.

Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus.

Journal: Clinical pharmacokinetics

Published: February 01, 2015

Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs.

Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs.

Journal: The AAPS journal

Published: December 17, 2014

Population pharmacokinetic/pharmacodynamic analysis of the DPP-4 inhibitor linagliptin in Japanese patients with type 2 diabetes mellitus.

Population pharmacokinetic/pharmacodynamic analysis of the DPP-4 inhibitor linagliptin in Japanese patients with type 2 diabetes mellitus.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Published: January 08, 2014

Population pharmacokinetics of afatinib, an irreversible ErbB family blocker, in patients with various solid tumors.

Population pharmacokinetics of afatinib, an irreversible ErbB family blocker, in patients with various solid tumors.

Journal: Cancer chemotherapy and pharmacology

Published: November 29, 2013

Showing 1-12 of 22

Last Updated: 09/26/2026